TILRAY BRANDS INC

Tilray CFO’s insider trades reveal strategic confidence: buying from vesting PSUs, selling tax‑efficiently, and holding 165,574 shares amid a 234% YTD rally.

Tilray CFO’s 10k‑share buy signals confidence—explore what insider buying means for investors amid a volatile cannabis stock.

Tilray CEO Simon Irwin buys 428k shares—signals confidence amid losses, cash‑flow worries and a pivot to high‑margin oral cannabis products.

Tilray insiders surge: Renah’s July 2026 buys signal confidence amid a 13% drop, offering investors a rare glimpse into top‑management strategy and potential rebound.

Tilray insider sale analysis: What David Hopkinson’s April 21 sale signals for investors, volatility, and long‑term confidence.

Tilray insiders cautiously add RSUs, boosting confidence post‑reverse split; investors eye earnings and cannabis legal shifts for stability.